Skip to main content
Log in

Lysosomal protease cathepsin D is a prognostic marker in endometrial cancer

  • Experimental Oncology
  • Published:
British Journal of Cancer Submit manuscript

Abstract

The present study investigates the prognostic value of immunohistochemically detected cathepsin D expression in endometrial adenocarcinoma. Patients with surgically treated endometrial adenocarcinoma FIGO stages I-III and consecutive irradiation therapy were included in the study. When we performed immunohistochemistry to detect cathepsin D in 115 tissue specimens 35 cases showed a positive reaction. In the univariate analysis cathepsin D expression showed significant prognostic value for overall survival (P-value = 0.007). In the multivariate analysis with established prognostic parameters (stage, grade) we found an independent prognostic value for cathepsin D (P-value = 0.002, relative risk = 3.8, 95% confidence interval 1.4 - 10.0). Immunohistochemical detection of cathepsin D could aid in predicting prognosis and planning therapy for patients with endometrial adenocarcinoma.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lösch, A., Kohlberger, P., Gitsch, G. et al. Lysosomal protease cathepsin D is a prognostic marker in endometrial cancer. Br J Cancer 73, 1525–1528 (1996). https://doi.org/10.1038/bjc.1996.287

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/bjc.1996.287

  • Springer Nature Limited

This article is cited by

Navigation